Tipiracil
Back to searchMolecule Structure
Scientific Name
Tipiracil
Description of the Drug
Tipiracil is a thymidine phosphorylase inhibitor used as an adjunct treatment of adult patients with certain types of gastric or colorectal malignancies.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09343
http://www.drugbank.ca/drugs/DB09343
Brand Name(s)
Not Available
Company Owner(s)
Taiho Oncology Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Thymidine phosphorylase | SINGLE PROTEIN | INHIBITOR | CHEMBL3106 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1682960 | ||||
| DrugBank | DB09343 | ||||
| PubChem: Thomson Pharma | 15121970 | 14749635 | |||
| PubChem | 6323266 | ||||
| LINCS | LSM-45561 | ||||
| Nikkaji | J1.090.874D | ||||
| BindingDB | 20079 | 50531739 | |||
| DrugCentral | 4893 | ||||
| Brenda | 135441 | 42314 | 77370 | 155422 | 37778 |
| ChemicalBook | CB62744247 | ||||
| Guide to Pharmacology | 8696 | ||||
| rxnorm | TIPIRACIL | TIPIRACIL HYDROCHLORIDE | |||
| ChEBI | 90879 | ||||
| ZINC | ZINC000100032379 |
